These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15122006)

  • 1. Pulmonary edema and possible pneumonitis associated with celecoxib.
    Olin JL; Chan A; Lazarus DS
    Ann Pharmacother; 2004 Jun; 38(6):1086. PubMed ID: 15122006
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis.
    Cummins R; Wagner-Weiner L; Paller A
    J Rheumatol; 2000 Dec; 27(12):2938-40. PubMed ID: 11128692
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
    Wolfe F; Zhao S; Pettitt D
    J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of celecoxib, a COX-2 inhibitor, in familial adenomatous polyposis].
    Wullen B; Mühlhöfer A; Zoller WG
    Z Gastroenterol; 2001 Apr; 39(4):335-7. PubMed ID: 11367984
    [No Abstract]   [Full Text] [Related]  

  • 5. Safer arthritis drugs on the horizon.
    Harv Health Lett; 1998 Apr; 23(6):7. PubMed ID: 9577257
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective celecoxib-associated anaphylactoid reaction.
    Gagnon R; Julien M; Gold P
    J Allergy Clin Immunol; 2003 Jun; 111(6):1404-5. PubMed ID: 12789245
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclooxygenase-2 inhibition and renal function.
    Pfister AK; Crisalli RJ; Carter WH
    Ann Intern Med; 2001 Jun; 134(11):1077; author reply 1078. PubMed ID: 11388824
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.
    Ta LE; Dionne RA
    Pain; 2004 Sep; 111(1-2):13-21. PubMed ID: 15327804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
    Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
    Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 2C9 genotype: impact on celecoxib safety and pharmacokinetics in a pediatric patient.
    Stempak D; Bukaveckas BL; Linder M; Koren G; Baruchel S
    Clin Pharmacol Ther; 2005 Sep; 78(3):309-10. PubMed ID: 16153401
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-reactivity and sulfonamide antibiotics.
    Wetstone HJ
    N Engl J Med; 2004 Jan; 350(3):302-3; author reply 302-3. PubMed ID: 14732937
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
    Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
    Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of clinical trials of analgesia.
    Katz N
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):605; author reply 606. PubMed ID: 14762388
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population.
    Hartung DM; Touchette DR; Ketchum KL; Haxby DG; Goldberg BW
    Clin Ther; 2004 Sep; 26(9):1518-32. PubMed ID: 15531015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
    Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective COX-2 inhibition improves endothelial function in coronary artery disease].
    Schultz O; Buttgereit F
    Z Rheumatol; 2003 Aug; 62(4):422-4. PubMed ID: 12928948
    [No Abstract]   [Full Text] [Related]  

  • 19. COX-2 inhibition: an advance or only pharmaceutical "hype"?
    Simon LS
    Arthritis Rheum; 2001 Jun; 45(3):209-15. PubMed ID: 11409659
    [No Abstract]   [Full Text] [Related]  

  • 20. [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].
    Lamarque D
    Bull Cancer; 2004 May; 91 Spec No():S117-24. PubMed ID: 15239340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.